Lactoferrin of oral fluid is normal and in Alzheimer's disease: laboratory and diagnostic aspects (review of literature)
- PMID: 35575393
- DOI: 10.51620/0869-2084-2022-67-4-207-212
Lactoferrin of oral fluid is normal and in Alzheimer's disease: laboratory and diagnostic aspects (review of literature)
Abstract
The article discusses the clinical value of determining the lactoferrin protein in oral fluid - one of the representatives of the saliva proteome. The review is based on the analysis of modern literature, including systematic reviews, the results of multicenter prospective studies, review and original articles by leading experts in this field, presented in the databases PubMed, Scopus, CyberLeninka. The problems of the preanalytical stage, methods for determining lactoferrin are highlighted and information about its content in mixed saliva according to various authors is provided. Special attention is paid to the clinical and diagnostic value of the level of salivary lactoferrin in Alzheimer's disease. According to most authors, the diagnostic sensitivity of this parameter ranges from 87 to 100%. Some mechanisms of the relationship between this protein and the central nervous system (CNS) are shown. In conclusion, it is concluded that salivary lactoferrin can be an "indicator" of the formation of amyloid plaques and can be considered as one of the reliable biomarkers of Alzheimer's disease. This opinion is based both on fundamental ideas about the global relationship between innate immunity and the central nervous system, and on clinical data. The special advantage of this laboratory test is its non-invasiveness, which makes it more preferable in comparison with the determination of amyloid and tau proteins in the cerebrospinal fluid and blood.
Keywords: Alzheimer’s disease; lactoferrin; oral fluid; saliva.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population.EBioMedicine. 2021 May;67:103361. doi: 10.1016/j.ebiom.2021.103361. Epub 2021 May 8. EBioMedicine. 2021. PMID: 33975253 Free PMC article.
-
A data-driven model of biomarker changes in sporadic Alzheimer's disease.Brain. 2014 Sep;137(Pt 9):2564-77. doi: 10.1093/brain/awu176. Epub 2014 Jul 9. Brain. 2014. PMID: 25012224 Free PMC article.
-
Decreased salivary lactoferrin levels are specific to Alzheimer's disease.EBioMedicine. 2020 Jul;57:102834. doi: 10.1016/j.ebiom.2020.102834. Epub 2020 Jun 22. EBioMedicine. 2020. PMID: 32586758 Free PMC article.
-
Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.J Alzheimers Dis. 2019;68(1):267-279. doi: 10.3233/JAD-180816. J Alzheimers Dis. 2019. PMID: 30741681
-
Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.Drugs Today (Barc). 2007 Jun;43(6):423-31. doi: 10.1358/dot.2007.43.6.1067341. Drugs Today (Barc). 2007. PMID: 17612711 Review.
Cited by
-
Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group.Alzheimers Dement. 2025 Feb;21(2):e14420. doi: 10.1002/alz.14420. Epub 2024 Dec 30. Alzheimers Dement. 2025. PMID: 39737743 Free PMC article. Review.
-
Lactoferrin: A glycoprotein that plays an active role in human health.Front Nutr. 2023 Jan 5;9:1018336. doi: 10.3389/fnut.2022.1018336. eCollection 2022. Front Nutr. 2023. PMID: 36712548 Free PMC article. Review.
References
-
- Bazarnyi V.V., Sidenkova A.P., Rezaikin A.V., Myakotnykh V.S., Borovkova T.A., Sel’kina E.O. et al. The possibility of using the results of the study of oral fluid and buccal epithelium in the diagnosis of Alzheimer’s disease. Uspekhi gerontologii. 2021; 34(4): 550-7. (in Russian)
-
- Melguizo-Rodríguez L., Costela-Ruiz V.J., Manzano-Moreno F.J., Ruiz C., Illescas-Montes R. Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies. Int. J. Mol. Sci. 2020; 21(14): 5173.
-
- Castagnola M., Scarano E., Passali G.C., Messana I., Cabras T., Iavarone F. et al. Salivary biomarkers and proteomics: future diagnostic and clinical utilities. Acta Otorhinolaryngol. Ital. 2017; 37(2): 94-101.
-
- Chojnowska S., Baran T., Wilińska I., Sienicka P., Cabaj-Wiater I., Knaś M. Human saliva as a diagnostic material. Adv. Med. Sci. 2018; 63(1): 185-91.
-
- Khurshid Z., Warsi I., Moin S.F., Slowey P.D., Latif M., Zohaib S. et al. Biochemical analysis of oral fluids for disease detection. Adv. Clin. Chem. 2021; 100: 205-53.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical